DCM Shriram posted a strong full-year FY2025, with consolidated net revenue rising 11% YoY to Rs 12,077 crore and PAT surging 35% to Rs 604 crore. Full-year EPS came in at Rs 38.75 versus Rs 28.67 in FY24. Shares rallied over 10% on May 6, 2025, following the earnings announcement before giving back gains on macro headwinds.
About DCM Shriram
DCM Shriram Limited (NSE: DCMSHRIRAM; BSE: 523367) is a diversified and integrated Indian conglomerate headquartered in New Delhi, with roots going back to the DCM Group legacy. The company operates across three broad pillars: Agri-Rural businesses (Sugar and Ethanol, Shriram Farm Solutions, Bioseed, and Fertilizer), Chemicals and Vinyl (Caustic Soda, PVC, Calcium Carbide, and downstream chemicals), and Value-Added Products (Fenesta Building Systems). Agri-Rural accounts for 61% of revenue, Chemicals and Vinyl for 29%, and Value-Added businesses for the remaining 7%.
As of March 2026, DCM Shriram carries a market capitalization of approximately Rs 15,878 crore and a P/E ratio of 26.28x. The company employs 6,255 people across 12 locations in India and the Philippines. Its credit rating stands at AA+/Stable, assigned by ICRA, reflecting its diversified business model and strong capital structure. The company declared a final dividend of Rs 3.40 per share for FY25, bringing the total FY25 dividend to Rs 9.00 per share (450% on face value of Rs 2).
Top Financial Highlights
- Full-year consolidated net revenue from operations reached Rs 12,077 crore, up 11% YoY from Rs 10,922 crore in FY24
- Full-year Profit After Tax (PAT) surged 35% YoY to Rs 604 crore versus Rs 447 crore in FY24
- Full-year PBDIT rose 35% to Rs 1,472 crore from Rs 1,089 crore in FY24
- Full-year EPS stood at Rs 38.75, up from Rs 28.67 in FY24, a growth of 35.16%
- Q4 FY25 net revenue grew 20% YoY to Rs 2,877 crore; Q4 PAT jumped 52% to Rs 179 crore
- Q4 EBITDA expanded 52.8% to Rs 405 crore, with EBITDA margin improving to 14.1% from 11.1% in Q4 FY24
- Chemicals and Vinyl segment revenue grew 24% to Rs 3,562 crore in FY25, with PBIT surging 343% to Rs 407 crore
- Shriram Farm Solutions revenue rose 21% to Rs 1,436 crore with PBIT up 26% to Rs 279 crore
- Sugar and Ethanol revenue grew 4% to Rs 3,862 crore, though PBIT fell 28% due to higher cane input costs
- Bioseed revenue increased 17% to Rs 648 crore with PBIT up 194% to Rs 58 crore
- Cash flow from operating activities improved 42.1% YoY to Rs 1,128 crore (Rs 11,278 million)
- Net debt stood at Rs 1,395 crore at the end of Q4 FY25, slightly lower than Rs 1,430 crore a year ago
- Board recommended a final dividend of Rs 3.40 per share; total FY25 dividend at Rs 9.00 per share
- Finance costs increased to Rs 153 crore in FY25 from Rs 88 crore in FY24, mainly due to lower interest capitalization
Beat or Miss?
| Metric | Reported (FY25) | Estimated / FY24 Baseline | Difference / Analysis |
| Net Revenue | Rs 12,077 crore | Rs 10,922 crore (FY24) | +11% YoY growth |
| PBDIT | Rs 1,472 crore | Rs 1,089 crore (FY24) | +35% YoY, well above trend |
| PAT | Rs 604 crore | Rs 447 crore (FY24) | +35% YoY, strong beat vs prior year |
| EPS (Diluted) | Rs 38.75 | Rs 28.67 (FY24) | +35.16% YoY improvement |
| EBITDA Margin (Q4) | 14.10% | 11.1% (Q4 FY24) | 300 bps expansion |
| Q4 Revenue | Rs 2,877 crore | Rs 2,399 crore (Q4 FY24) | +20% YoY |
| Q4 Net Profit | Rs 179 crore | Rs 118 crore (Q4 FY24) | +52% YoY |
| Chemicals PBIT | Rs 407 crore | Rs 92 crore (FY24) | +343% YoY driven by capacity expansion |
| Sugar PBIT | Rs 304 crore | Rs 424 crore (FY24) | -28% YoY on higher cane input costs |
What Leadership Is Saying?
Management Statement on Strategy and Macro Outlook (Chairman and MD Joint Statement):
“The growth patterns in world economy are becoming very uncertain, with projections indicating a global growth rate of less than 3% for 2025 and 2026. The imposition of reciprocal tariffs by the United States and consequent retaliation by China have sent shockwaves through international markets, extending far beyond bilateral relations, influencing supply chains, inflation rates, and economic stability worldwide.
We have commissioned most of our major projects in Chemicals in the current year with reasonable capacity utilisation, leading to volume led growth and better cost structure. The chlorine downstream projects, once operational, will further enhance the utilization rates of Chlor-alkali and strengthen the Chemicals business.”
Management Statement on Business Expansion and Balance Sheet:
“Leveraging our strong balance sheet, we are strategically expanding into adjacencies to drive scale, enhance operational integration, and maximize cost efficiencies, positioning ourselves for sustained competitive advantage.
Shriram Farm Solutions continues to focus on providing research driven and differentiated products to farmers and leveraging digital platforms to expand farmer engagement. Fenesta business is strategically prioritizing accelerated growth in its core segment, while also expanding into new revenue platforms such as Facade, Wooden doors and Hardware.”
Historical Performance
DCM Shriram YoY Annual Comparison
| Category | FY2025 | FY2024 | Change (%) |
| Net Revenue from Operations | Rs 12,077 crore | Rs 10,922 crore | +11% |
| PBDIT | Rs 1,472 crore | Rs 1,089 crore | +35% |
| PAT (Net Income) | Rs 604 crore | Rs 447 crore | +35% |
| EPS (Rs) | Rs 38.75 | Rs 28.67 | +35.16% |
| Finance Cost | Rs 153 crore | Rs 88 crore | +74% |
| Depreciation and Amortization | Rs 410 crore | Rs 303 crore | +35% |
| Gross Profit Margin | 11.60% | 9.50% | +210 bps |
| Net Profit Margin | 5.30% | 4.30% | +100 bps |
| Cash Flow from Operations | Rs 1,128 crore | Rs 794 crore | 42% |
Q4 FY25 vs Q4 FY24 Quarterly Comparison
| Category | Q4 FY2025 | Q4 FY2024 | Change (%) |
| Net Revenue | Rs 2,877 crore | Rs 2,399 crore | +20% |
| PBDIT | Rs 427 crore | Rs 289 crore | +47% |
| PAT | Rs 179 crore | Rs 118 crore | +52% |
| EPS (Diluted) | Rs 11.47 | Rs 7.55 | +52% |
| EBITDA Margin | 14.10% | 11.10% | +300 bps |
Competitor Comparison
Diversified Chemicals and Agri Sector Peers FY2025
| Category | DCM Shriram (FY25) | DCM Shriram (FY24) | Change (%) |
| Revenue (Rs crore) | 12,077 | 10,922 | +11% |
| Net Income (Rs crore) | 604 | 447 | +35% |
| OPM % | 10.89% | 8.99% | +190 bps |
| Category | Grasim Industries (FY25) | Grasim Industries (FY24) | Change (%) |
| Revenue (Rs crore) | 1,48,478 | 1,30,978 | +13% |
| Net Income (Rs crore) | 7,460 | 9,837 | -24% |
| EPS (Rs) | 54.45 | 84.71 | -36% |
| Category | Tata Chemicals (FY25) | Tata Chemicals (FY24) | Change (%) |
| Revenue (Rs crore) | 14,887 | 15,421 | -3% |
| PAT (Rs crore) | 479 | 1,310 | -63% |
| EBITDA (Rs crore) | 1,953 | 2,847 | -31% |
DCM Shriram significantly outperformed both large-cap peers on profitability growth in FY25. While Grasim’s revenue was 12x larger due to its cement and financial services businesses, its PAT fell 24% on heavy investments in its Birla Opus paints business. Tata Chemicals reported sharply weaker earnings due to oversupply in the global soda ash market, while DCM Shriram benefited from volume-led growth in caustic soda following major capacity expansion.
How the Market Reacted?
DCM Shriram shares surged more than 10% on May 6, 2025, the day following the announcement of Q4 and full-year FY25 results, as the market responded to the 52% jump in Q4 net profit and expansion in EBITDA margins. Ahead of the result itself, shares had already closed 4% higher at Rs 1,021 on the BSE on May 5, reflecting pre-result optimism.
However, the initial euphoria was short-lived. In the weeks following the results, DCM Shriram shares crashed nearly 15% in a single session, wiping out approximately Rs 1,842 crore in market capitalization, as investors grew concerned about global PVC oversupply, pressure on chloro-vinyl margins, and delays in the Epichlorohydrin plant commissioning due to technical difficulties.
